Jim Cramer says health care is the 'cold' hedge your AI-heavy portfolio is missing — and shares 4 stocks to consider

3 weeks ago 13

Clay Halton

Tue, April 28, 2026 astatine 10:45 AM CDT 4 min read

Artificial quality has helped propulsion large indexes to caller highs. But according to Jim Cramer (1), that momentum whitethorn beryllium precisely wherefore investors should commencement looking elsewhere.

The AI rally has besides go progressively concentrated, with the 10 largest companies present accounting for astir 40% of the S&P 500, according to RBC Wealth Management (2).

Must Read

With some the S&P 500 and Nasdaq Composite climbing, Cramer is informing that immoderate of the biggest winners (especially successful tech) could beryllium susceptible to a pullback aft specified a beardown run. His takeaway is simple: portfolios that thin excessively heavy connected 1 inclination tin rapidly get exposed if sentiment shifts.

Instead, he's pointing to a portion of the marketplace that's been mostly ignored.

Why wellness attraction could beryllium the 'cold' hedge investors request

Cramer calls wellness attraction the "cold" broadside of the marketplace (3) — not due to the fact that the fundamentals are weak, but due to the fact that capitalist enthusiasm has cooled. That disconnect is precisely what makes it appealing.

While tech stocks tied to AI person surged, galore wellness attraction names person lagged oregon adjacent declined. In 1 caller quarter, wellness attraction fell much than 7% portion exertion gained implicit 20%, according to concern reports utilizing S&P Dow Jones Indices information (4).

This spread is what Cramer sees arsenic an accidental for investors looking to rebalance.

He highlighted 4 companies successful peculiar (5):

  • CVS Health (NYSE: CVS)

  • Cardinal Health (NYSE: CAH)

  • Johnson & Johnson (NYSE: JNJ)

  • UnitedHealth Group (NYSE: UNH)

Each offers a antithetic mode to summation vulnerability to the assemblage from security and retail pharmacies to cause organisation and pharmaceutical development.

For example, Cramer argues CVS could payment arsenic competitors shrink oregon disappear, portion Cardinal Health is expanding into higher-growth services beyond its accepted organisation business.

Meanwhile, helium says Johnson & Johnson's cause pipeline and UnitedHealth's standard and net spot springiness them staying powerfulness adjacent if broader marketplace conditions shift.

The communal thread is that these companies aren't riding the AI wave, which whitethorn beryllium precisely wherefore they could assistance cushion portfolios if that question loses momentum.

Read Entire Article